BRAF and colorectal cancer: In addition, our current analysis (N>1200) represents a large single study to date (Additional file6: Table S6)[26-29,32-74], examining KRAS codon 61 and 146 mutations, in relation to other important molecular features in colorectal cancers, such as status of CIMP, MSI, BRAF and PIK3CA mutations.